Outcomes
|
1. Efficacy will be determined by changes in three laboratory parameters which will serve assurrogates for potential clinical benefit: nitric oxide, Gardos channel activity, and RBC density. 2. sVCAM, Nitrotyrosine, 8-iso-PGF2a, Ektacytometry, endothelin-1, fetal hemoglobin (HbF) and echocardiogram results as well as clinical outcomes including hospitalizations, ER visits, and painmedication use. |